In the early pathological state of AD, glucose utilization (up to 45%) is reduced, which is closely related to the alteration of insulin signaling
doi: 10.1089/15209150252924094 103 RiddleMFriasJZhangBMaierHBrownCLutzKet al
So stay tuned until the end
Antibody Behavior of monoclonal therapeutic antibodies in angioedemas Lszl Cervenak Department of Internal Medicine and Haematology, Semmelweis University, Budapest, Hungary Correspondence: Lszl Cervenak ([email protected]) Allergy, Asthma & Clinical Immunology 2025, 21(Suppl 2) :I-04 Monoclonal antibodies are nowadays the most utilized form of large-molecule drugs
Emerging evidence supports a phenotype-guided approach that aligns therapy with dominant comorbidities such as atherosclerotic cardiovascular disease, heart failure, chronic kidney disease, and obesity
The 2nd GLP-1-Based Therapeutics Summit returns to tackle the challenges in best-in-class GLP-1 development and indication expansion with new clinical data, new preclinical data, and 18+ expert speakers including Eli Lily, Regeneron, Roche, Novo Nordisk, Fractyl Health and more at the forefront of the field